Investor Alert: Upcoming Deadlines in Shareholder Litigation Involving Teva Pharmaceuticals and Tri-Tech Holdings, Inc.
January 07 2014 - 11:25AM
Business Wire
Holzer & Holzer reminds investors of upcoming deadlines for
applications to serve as lead plaintiff in securities class action
lawsuits against Teva Pharmaceuticals Industries Limited and
Tri-Tech Holdings, Inc.
Teva Pharmaceuticals Industries Limited
A class action lawsuit has been filed on behalf of investors who
purchased Teva (NYSE: TEVA) securities between January 1, 2012 and
October 29, 2013. The complaint alleges, among other things, that
Teva made false and misleading statements to investors during that
time that failed to disclose significant disagreements between the
company’s board of directors and senior management. On October 30,
2013, Teva’s CEO and President, Dr. Jeremy Levin, announced his
resignation from the company sending the price of Teva stock down
significantly.
The deadline to seek appointment as lead plaintiff in this
lawsuit, which is pending in the United States District Court for
the Southern District of New York, is February 24, 2014.
If you purchased shares between January 1, 2012 and October 29,
2013 and would like more information about your rights, please
contact the firm or visit www.holzerlaw.com.
Tri-Tech Holdings, Inc.
A class action lawsuit has been filed on behalf of investors who
purchased Tri-Tech Holdings (NASDAQ: TRIT) securities between March
26, 2012 and December 12, 2013 alleging the company violated the
federal securities laws by issuing false and misleading statements
to investors. According to the complaint, the company lacked
adequate internal controls rendering certain of its statements made
during that time misleading. On December 12, 2013, it was revealed
that the company’s former Chief Executive Officer was terminated
due to alleged violations of the company’s policies on wire
transfers and the Nasdaq halted trading of TRIT following an 11%
decline in share price.
The deadline to seek appointment as lead plaintiff in this
lawsuit, which is pending in the United States District Court for
the Southern District of New York, is February 18, 2014. More
information about the lawsuit and the firm are available at
www.holzerlaw.com.
Investors Are Encouraged To Contact The Firm
Investors that suffered significant losses investing in either
of these companies during the specified times who are interested in
potentially serving as lead plaintiff in the respective class
actions are encouraged to contact Marshall P. Dees, Esq. by email
at mdees@holzerlaw.com or via toll-free telephone at (888) 508-6832
to discuss their legal rights.
A lead plaintiff is a representative party appointed by the
court to act on behalf of other class members in directing the
litigation. Any member of the purported class may move the court to
serve as lead plaintiff through counsel of their choice, or may
choose to do nothing and remain an absent class member.
Holzer & Holzer LLC dedicates its practice to vigorous
representation of shareholders and investors in litigation
nationwide, including shareholder class action and derivative
litigation. More information about the firm is available through
its website, www.holzerlaw.com. and upon request from the firm.
Holzer & Holzer, LLC has paid for the dissemination of this
promotional communication, and Corey D. Holzer is the attorney
responsible for its content.
Holzer & Holzer, LLCMarshall P. Dees, Esq., 888-508-6832
(toll-free)mdees@holzerlaw.com
Tri Tech (CE) (USOTC:TRITF)
Historical Stock Chart
From Oct 2024 to Nov 2024
Tri Tech (CE) (USOTC:TRITF)
Historical Stock Chart
From Nov 2023 to Nov 2024